Skip to main content
Clinical Trials/TCTR20210221001
TCTR20210221001
Completed
N/A

Severity of ototoxicity and long-term hearing outcome in pediatric oncology patients receiving cisplatin in a university hospital

none0 sites47 target enrollmentFebruary 21, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
sensorineural hearing lossototoxicity
Sponsor
none
Enrollment
47
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 21, 2021
End Date
December 31, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • 1\.pediatric solid tumor patients including neuroblastoma, hepatoblastoma, osteosarcoma, and germ cell tumor who were younger than 15 years old and received cisplatin\-based chemotherapy at the Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand from January, 2007 to December, 2019, 2\.Patients were evaluated baseline hearing with audiogram and/or auditory steady\-state response (ASSR) pre\- or within 1 month of initiation of cisplatin and were followed up the hearing test at least 2 sequential times.

Exclusion Criteria

  • Patients who had anatomical defect of ear and renal dysfunction before treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials